Experienced in Hepatitis B

Uta Merle

Heidelberg, BW, DE 
Experienced in Hepatitis B
Heidelberg, BW, DE 
OverviewLocationsClinical Research

Overview

Uta Merle practices in Heidelberg, Germany. Ms. Merle is rated as an Experienced expert by MediFind in the treatment of Hepatitis B. Her top areas of expertise are Hepatocerebral Degeneration, Wilson Disease, COVID-19, Liver Transplant, and Thrombectomy.

Her clinical research consists of co-authoring 169 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Hepatitis B.

Gender
Female

Locations

Heidelberg, BW, Germany
Other Locations
Salem, BW 69120, Germany
Wuerzburg, BY, Germany
Hamburg, HH, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

RescuE pLAsma eXchange in Severe COVID-19 (RELAX Severe COVID-19)
RescuE pLAsma eXchange in Severe COVID-19 (RELAX Severe COVID-19)
Enrollment Status: Terminated
Publish Date: April 15, 2025
Intervention Type: Other
Study Phase: Not Applicable
Multicentre, Open-Label, Randomised, Two-Arm, Parallel-Group, Superiority Study to Assess Bioavailability and Practicability of Envarsus® Compared With Advagraf® in de Novo Liver Transplant Recipients (EnGraft)
Multicentre, Open-Label, Randomised, Two-Arm, Parallel-Group, Superiority Study to Assess Bioavailability and Practicability of Envarsus® Compared With Advagraf® in de Novo Liver Transplant Recipients (EnGraft)
Enrollment Status: Active_not_recruiting
Publish Date: April 06, 2025
Intervention Type: Drug
Study Phase: Phase 4
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
View 2 Less Clinical Trials

169 Total Publications

Impact of Handling Perception and Language Barriers on Virologic Response to Daily Subcutaneous Bulevirtide in Hepatitis D.
Impact of Handling Perception and Language Barriers on Virologic Response to Daily Subcutaneous Bulevirtide in Hepatitis D.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: August 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Merle's expertise for a condition
ConditionClose
View All 34 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile